FDA OKs First Treatment for Lambert-Eaton Myasthenic Syndrome

Amifampridine (Firdapse) is approved for adults with Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder characterized by muscle weakness.
FDA Approvals

Source link

Related posts

ECTRIMS 2018: Expect 'New Insights and Complexity' in MS


Tolerance to Cannabidiol for Treatment-Resistant Epilepsy Seen Over Time


Science Daily: Compound identified that protects against neurodegeneration


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy